CoChat

Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45

Siddiqi, Sindhu, Verney, Charlotte, Dargan, Paul, Wood, David M. · 2015 · Clinical Toxicology
Cited by 112

The DOI matches its Crossref record.

Abstract

INTRODUCTION: 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45) is a novel psychoactive substance available over the Internet. MT-45 is an opioid-like compound. This study provides an overview of availability, use and desired and unwanted effects of MT-45 through triangulation of available data sources. METHODS: Searches of the published scientific literature and 'grey' information sources, using the keywords 'MT 45', 'MT-45' and '1-cyclohexyl-4-(1,2-diphenylethyl)piperazine' were undertaken in June 2014 to identify information on the availability, prevalence of use and desired/unwanted effects of MT-45. In addition an Internet snapshot survey in English was undertaken in May 2014 to determine the availability and cost of MT-45. RESULTS: In June 2014 we were unable to identify any studies reporting the prevalence of use of MT-45. The Internet snapshot study identified 17 Internet sites selling MT-45. Information on price was available from 9 sites, with the mean price of MT-45 decreased with increasing purchase amounts from US$57.60 ± 19.37 per gram for a 1-g purchase to US$3.36 ± 1.83 per gram for a 1-kg purchase. We identified one published scientific paper reporting on the acute harms in nine cases of analytically confirmed MT-45 toxicity, one US government report relating to two MT-45-related deaths and 20 user reports on Internet discussion forums relating to the use of MT-45. All these suggest that the desired and unwanted effects of MT-45 are similar to those seen with other opioids, and that the opioid-like unwanted effects may be reversed with the opioid antagonist naloxone. There were user reports of MT-45 being used in heroin withdrawal and of 'withdrawal symptoms' after use, suggesting that long-term use may be associated with dependency as seen with other opioids. CONCLUSIONS: Combining published scientific literature and 'grey' information sources, we have demonstrated that MT-45 has opioid-like desired and unwanted effects. Whilst the information is limited at the moment, it has the potential to have similar dependence liability to other opioids.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/15563650.2014.983239

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 112

Metadata

Authors
Siddiqi, S., Verney, C., Dargan, P., & Wood, D. M.
Venue
Clinical Toxicology
Published
2014-11-28
Volume
53
Issue
1
Pages
54-59
ISSN
  • 0009-9309 (ISSN-L)
  • 1556-3650
  • 1556-9519
OpenAlex
W2166135044
Cited by
112
References
0
FWCI
10.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45. https://app.cochat.ai/papers/10.3109/15563650.2014.983239
The paper
Siddiqi, S., Verney, C., Dargan, P., & Wood, D. M. (2015). Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45. Clinical Toxicology. https://doi.org/10.3109/15563650.2014.983239

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.